SEARCH

SEARCH BY CITATION

References

  • Akil, M., Kolachana, B.S., Rothmond, D.A., Hyde, T.M., Weinberger, D.R. & Kleinman, J.E. (2003) Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23, 20082013.
  • Apud, J.A., Mattay, V., Chen, J., Kolachana, B.S., Callicott, J.H., Rasetti, R., Alce, G., Iudicello, J.E., Akbar, N., Egan, M.F., Goldberg, T.E. & Weinberger, D.R. (2007) Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology 32, 10111020.
  • Beck, A.T., Epstein, N., Brown, G. & Steer, R.A. (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56, 893897.
  • Bilder, R.M., Volavka, J., Lachman, H.M. & Grace, A.A. (2004) The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29, 19431961.
  • Boettiger, C.A., Mitchell, J.M., Tavares, V.C., Robertson, M., Joslyn, G., D'Esposito, M. & Fields, H.L. (2007) Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype. J Neurosci 27, 1438314391.
  • Brody, A.L., Mandelkern, M.A., Olmstead, R.E., Scheibal, D., Hahn, E., Shiraga, S., Zamora-Paja, E., Farahi, J., Saxena, S., London, E.D. & McCracken, J.T. (2006) Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 63, 808816.
  • Bruder, G.E., Keilp, J.G., Xu, H., Shikhman, M., Schori, E., Gorman, J.M. & Gilliam, T.C. (2005) Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry 58, 901907.
  • Burke, M.V., Ebbert, J.O. & Hays, J.T. (2008) Treatment of tobacco dependence. Mayo Clin Proc 83, 479483.
  • Cahill, K., Stead, L.F. & Lancaster, T. (2011) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev, CD006103.
  • Camara, E., Kramer, U.M., Cunillera, T., Marco-Pallares, J., Cucurell, D., Nager, W., Mestres-Misse, A., Bauer, P., Schule, R., Schols, L., Tempelmann, C., Rodriguez-Fornells, A. & Munte, T.F. (2010) The effects of COMT (Val108/158Met) and DRD4 (SNP −521) dopamine genotypes on brain activations related to valence and magnitude of rewards. Cereb Cortex 20, 19851996.
  • Chen, J., Lipska, B.K., Halim, N., Ma, Q.D., Matsumoto, M., Melhem, S., Kolachana, B.S., Hyde, T.M., Herman, M.M., Apud, J., Egan, M.F., Kleinman, J.E. & Weinberger, D.R. (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75, 807821.
  • Colilla, S., Lerman, C., Shields, P.G., Jepson, C., Rukstalis, M., Berlin, J., DeMichele, A., Bunin, G., Strom, B.L. & Rebbeck, T.R. (2005) Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics 15, 393398.
  • Colzato, L.S., Waszak, F., Nieuwenhuis, S., Posthuma, D. & Hommel, B. (2010) The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching. Neuropsychologia 48, 27642768.
  • Cox, R.W. (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29, 162173.
  • David, S.P., Johnstone, E.C., Churchman, M., Aveyard, P., Murphy, M.F. & Munafo, M.R. (2011) Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res 13, 157167.
  • Delgado, M.R., Locke, H.M., Stenger, V.A. & Fiez, J.A. (2003) Dorsal striatum responses to reward and punishment: effects of valence and magnitude manipulations. Cogn Affect Behav Neurosci 3, 2738.
  • Dickinson, D. & Elvevag, B. (2009) Genes, cognition and brain through a COMT lens. Neuroscience 164, 7287.
  • Dreher, J.C., Kohn, P., Kolachana, B., Weinberger, D.R. & Berman, K.F. (2009) Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA 106, 617622.
  • Egan, M.F., Goldberg, T.E., Kolachana, B.S., Callicott, J.H., Mazzanti, C.M., Straub, R.E., Goldman, D. & Weinberger, D.R. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98, 69176922.
  • Enoch, M.A., Shen, P.H., Xu, K., Hodgkinson, C. & Goldman, D. (2006a) Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol 20, 1926.
  • Enoch, M.A., Waheed, J.F., Harris, C.R., Albaugh, B. & Goldman, D. (2006b) Sex differences in the influence of COMT Val158Met on alcoholism and smoking in plains American Indians. Alcohol Clin Exp Res 30, 399406.
  • Farrell, S.M., Tunbridge, E.M., Braeutigam, S. & Harrison, P.J. (2012) COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-o-methyltransferase inhibition. Biol Psychiatry 71, 538544.
  • Franken, I.H., van Strien, J.W. & Kuijpers, I. (2010) Evidence for a deficit in the salience attribution to errors in smokers. Drug Alcohol Depend 106, 181185.
  • Friedman, L., Glover, G.H., Krenz, D. & Magnotta, V. (2006) Reducing inter-scanner variability of activation in a multicenter fMRI study: role of smoothness equalization. Neuroimage 32, 16561668.
  • Garris, P.A. & Wightman, R.M. (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neurosci 14, 442450.
  • Gehricke, J.G., Loughlin, S.E., Whalen, C.K., Potkin, S.G., Fallon, J.H., Jamner, L.D., Belluzzi, J.D. & Leslie, F.M. (2007) Smoking to self-medicate attentional and emotional dysfunctions. Nicotine Tob Res 9 (Suppl. 4), S523S536.
  • Giakoumaki, S.G., Roussos, P. & Bitsios, P. (2008) Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Neuropsychopharmacology 33, 30583068.
  • Goldman-Rakic, P.S., Muly, E.C. III & Williams, G.V. (2000) D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31, 295301.
  • Heatherton, T.F., Kozlowski, L.T., Frecker, R.C. & Fagerstrom, K.O. (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86, 11191127.
  • Heishman, S.J., Singleton, E.G. & Moolchan, E.T. (2003) Tobacco Craving Questionnaire: reliability and validity of a new multifactorial instrument. Nicotine Tob Res 5, 645654.
  • Heishman, S.J., Singleton, E.G. & Pickworth, W.B. (2008) Reliability and validity of a Short Form of the Tobacco Craving Questionnaire. Nicotine Tob Res 10, 643651.
  • Hodgkinson, C.A., Yuan, Q., Xu, K., Shen, P.H., Heinz, E., Lobos, E.A., Binder, E.B., Cubells, J., Ehlers, C.L., Gelernter, J., Mann, J., Riley, B., Roy, A., Tabakoff, B., Todd, R.D., Zhou, Z. & Goldman, D. (2008) Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43, 505515.
  • Holroyd, C.B. & Coles, M.G. (2002) The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol Rev 109, 679709.
  • Hughes, J.R., Stead, L.F. & Lancaster, T. (2003) Antidepressants for smoking cessation. Cochrane Database Syst Rev, CD000031.
  • Johnstone, E.C., Elliot, K.M., David, S.P., Murphy, M.F., Walton, R.T. & Munafo, M.R. (2007) Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev 16, 10651069.
  • Kaenmaki, M., Tammimaki, A., Myohanen, T., Pakarinen, K., Amberg, C., Karayiorgou, M., Gogos, J.A. & Mannisto, P.T. (2010) Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice. J Neurochem 114, 17451755.
  • Knutson, B., Westdorp, A., Kaiser, E. & Hommer, D. (2000) FMRI visualization of brain activity during a monetary incentive delay task. Neuroimage 12, 2027.
  • Krugel, L.K., Biele, G., Mohr, P.N., Li, S.C. & Heekeren, H.R. (2009) Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions. Proc Natl Acad Sci USA 106, 1795117956.
  • Loughead, J., Wileyto, E.P., Valdez, J.N., Sanborn, P., Tang, K., Strasser, A.A., Ruparel, K., Ray, R., Gur, R.C. & Lerman, C. (2009) Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol Psychiatry 14, 820826.
  • Luijten, M., van Meel, C.S. & Franken, I.H. (2011) Diminished error processing in smokers during smoking cue exposure. Pharmacol Biochem Behav 97, 514520.
  • Marco-Pallares, J., Cucurell, D., Cunillera, T., Kramer, U.M., Camara, E., Nager, W., Bauer, P., Schule, R., Schols, L., Munte, T.F. & Rodriguez-Fornells, A. (2009) Genetic variability in the dopamine system (dopamine receptor D4, catechol-O-methyltransferase) modulates neurophysiological responses to gains and losses. Biol Psychiatry 66, 154161.
  • Martin-Soelch, C., Missimer, J., Leenders, K.L. & Schultz, W. (2003) Neural activity related to the processing of increasing monetary reward in smokers and nonsmokers. Eur J Neurosci 18, 680688.
  • Mattay, V.S., Goldberg, T.E., Fera, F., Hariri, A.R., Tessitore, A., Egan, M.F., Kolachana, B., Callicott, J.H. & Weinberger, D.R. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100, 61866191.
  • Mehta, M.A., Manes, F.F., Magnolfi, G., Sahakian, B.J. & Robbins, T.W. (2004) Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology (Berl) 176, 331342.
  • Meyer-Lindenberg, A., Kohn, P.D., Kolachana, B., Kippenhan, S., McInerney-Leo, A., Nussbaum, R., Weinberger, D.R. & Berman, K.F. (2005) Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 8, 594596.
  • Munafo, M.R., Johnstone, E.C., Guo, B., Murphy, M.F. & Aveyard, P. (2008) Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenet Genomics 18, 121128.
  • Nielsen, L., Knutson, B. & Carstensen, L.L. (2008) Affect dynamics, affective forecasting, and aging. Emotion 8, 318330.
  • Parrott, A.C., Garnham, N.J., Wesnes, K. & Pincock, C. (1996) Cigarette smoking and abstinence: comparative effects upon cognitive task performance and mood state over 24 hours. Hum Psychopharmacol Clin Exp 11, 391400.
  • Powell, J., Dawkins, L. & Davis, R.E. (2002) Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model. Biol Psychiatry 51, 151163.
  • Robinson, T.E. & Berridge, K.C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18, 247291.
  • Silagy, C., Lancaster, T., Stead, L., Mant, D. & Fowler, G. (2004) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, CD000146.
  • Sweitzer, M.M., Donny, E.C. & Hariri, A.R. (2012) Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction. Drug Alcohol Depend 123 (Suppl. 1), S59S71.
  • Tricomi, E., Balleine, B.W. & O'Doherty, J.P. (2009) A specific role for posterior dorsolateral striatum in human habit learning. Eur J Neurosci 29, 22252232.
  • Tucker, D.M., Luu, P., Frishkoff, G., Quiring, J. & Poulsen, C. (2003) Frontolimbic response to negative feedback in clinical depression. J Abnorm Psychol 112, 667678.
  • Tunbridge, E.M., Harrison, P.J. & Weinberger, D.R. (2006) Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60, 141151.
  • Wechsler, D. (1999) Wechsler Abbreviated Scale of Intelligence (WASI). The Psychological Corporation, San Antonio.
  • Yacubian, J., Sommer, T., Schroeder, K., Glascher, J., Kalisch, R., Leuenberger, B., Braus, D.F. & Buchel, C. (2007) Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci USA 104, 81258130.